Evaluate the Efficacy and Safety of Edoxaban on Prevention of Catheter-related Thrombosis (CRT) in Cancer Patients
Clinical trial NCT06149533 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06149533
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-30
- Primary completion
- 2026-05-30
- Enrollment
- 366
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.